Toxic role of K + channel oxidation in mammalian brain

Journal of Neuroscience

Volumn 32, Issue 12, 2012, Pages 4133-4144

  Cotella, Diego ^a,d   Hernandez Enriquez, Berenice ^a   Wu, Xilong ^a   Li, Ruiqiong ^a   Pan, Zui ^a   Leveille, Joseph ^a   Link, Christopher D ^b   Oddo, Salvatore ^c   Sesti, Federico ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID BETA PROTEIN; CYSTEINE; REACTIVE OXYGEN METABOLITE; SHAB POTASSIUM CHANNEL;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CAENORHABDITIS ELEGANS; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYO; FEMALE; FLUOROMETRY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC ANIMAL; WESTERN BLOTTING;

2,2'-DIPYRIDYL; AGE FACTORS; ALANINE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; BRAIN; CAENORHABDITIS ELEGANS; CELLS, CULTURED; CRICETINAE; CRICETULUS; CYSTEINE; DISEASE MODELS, ANIMAL; DISULFIDES; ELECTRIC STIMULATION; EMBRYO, MAMMALIAN; FEMALE; FLUORESCEINS; HUMANS; HYDROGEN PEROXIDE; MALE; MASS SPECTROMETRY; MEMBRANE POTENTIALS; MICE; NEURONS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PRESENILIN-1; PROPANOLS; SHAB POTASSIUM CHANNELS; TRANSFECTION;

EID: 84863362633     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6153-11.2012     Document Type: Article

References (52)

1. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 75:1878-1888.
2. Bianchi L, Kwok SM, Driscoll M, Sesti F (2003) A potassium channel-MiRP complex controls neurosensory function in Caenorhabditis elegans. J Biol Chem 278:12415-12424.
3. Brocklehurst K (1979) Specific covalent modification of thiols: applications in the study of enzymes and other biomolecules. Int J Biochem 10:259-274.
4. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32:1050-1060.
5. Cai SQ, Sesti F (2009) Oxidation of a potassium channel causes progressive sensory function loss during aging. Nat Neurosci 12:611-617.
6. Canevari L, Clark JB, Bates TE (1999) Beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett 457:131-134.
7. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL (2003) Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8:345-352.
8. Chou JL, Shenoy DV, Thomas N, Choudhary PK, Laferla FM, Goodman SR, Breen GA (2011) Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease. J Proteomics 74:466-479.
9. Crouch PJ, Barnham KJ, Duce JA, Blake RE, Masters CL, Trounce IA (2006) Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide. J Neuro-chem 99:226-236.
10. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
11. HarmanD (1956) Aging:a theory based on free radical and radiation chemistry. J Gerontol 11:298-300.
12. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation bythe peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A 91:3270-3274.
13. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156.
14. Hernández-Enríquez B, Guemez-Gamboa A, Morán J (2011) Reactive oxygen species are related to ionic fluxes and volume decrease in apoptotic cerebellar granule neurons: role of NOX enzymes. J Neurochem 117:654-664.
15. Ju M, Stevens L, Leadbitter E, Wray D (2003) The Roles of N- and C-terminal determinants in the activation of the Kv2.1 potassium channel. J Biol Chem 278:12769-12778.
16. Kobrinsky E, Stevens L, Kazmi Y, Wray D, Soldatov NM (2006) Molecular rearrangements of the Kv2.1 potassium channel termini associated with voltage gating. J Biol Chem 281:19233-19240.
17. Kullmann DM (2002) The neuronal channelopathies. Brain 125:1177-1195.
18. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78:413-416.
19. Leung YM, Huang CF, Chao CC, Lu DY, Kuo CS, Cheng TH, Chang LY, Chou CH (2011) Voltage-gated K(+) channels play a role in cAMP-stimulated neuritogenesis in mouse neuroblastoma N2A cells. J Cell Physiol 226:1090-1098.
20. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795.
21. Link CD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92:9368-9372.
22. Link CD, Silverman MA, Breen M, Watt KE, Dames SA (1992) Characterization of Caenorhabditis elegans lectin-binding mutants. Genetics 131:867-881.
23. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452.
24. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15:1437-1449.
25. Mankouri J, Dallas ML, Hughes ME, Griffin SD, Macdonald A, Peers C, Harris M (2009) Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence. Proc Natl Acad Sci USA 106:15903-15908.
26. McManus MJ, Murphy MP, Franklin JL (2011) The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 31:15703-15715.
27. + channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res 91:478-486.
28. + channel critical to dynamic control of neuronal excitability. Neurotoxi-cology 26:743-752.
29. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767.
30. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Mether-ate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
31. Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E (2003) Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 23:4798-4802.
32. + channel ancillary subunits regulate taste sensitivity in Caenorhabditis elegans. J Biol Chem 280:21893-21899.
33. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183-4187.
34. Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, Quinn J (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13:1225-1240.
35. Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA, Levitan ES, Aizenman E (2007) Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci USA 104:3568-3573.
36. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Dröse S, Brandt U, Savaskan E, Czech C, Götz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phos-phorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106:20057-20062.
37. Rohn TT, Head E (2008) Caspase activation in Alzheimer's disease: early to rise and late to bed. Rev Neurosci 19:383-393.
38. Rohn TT, Head E (2009) Caspases as therapeutic targets in Alzheimer's disease: is it time to"cut"to the chase? Int J Clin Exp Pathol 2:108-118.
39. Rojas P, Garst-Orozco J, Baban B, de Santiago-Castillo JA, Covarrubias M, Salkoff L (2008) Cumulative activationof voltage-dependent KVS-1 potassium channels. J Neurosci 28:757-765.
40. Sakmann B, Neher E, eds (1995) Single-channel recording, Ed 2. New York: Plenum.
41. Saraiva LM, Seixas da Silva GS, Galina A, da-Silva WS, Klein WL, Ferreira ST, De Felice FG (2010) Amyloid-beta triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One 5:e15230.
42. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N (2008) Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol 43:488-492.
43. Sesti F, Liu S, Cai SQ (2010) Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration? Trends Cell Biol 20:45-51.
44. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simo-nyi A, Sun GY (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106:45-55.
45. 2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94:1711-1718.
46. + currents in neurons. Neurosci Res 42:7-14.
47. Squier TC (2001) Oxidative stress and protein aggregation during biological aging. Exp Gerontol 36:1539-1550.
48. Sultana R, Perluigi M, Butterfield DA (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 8:2021-2037.
49. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS (2005) ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 19:597-598.
50. Vernino S (2007) Autoimmune and paraneoplastic channelopathies. Neu-rotherapeutics 4:305-314.
51. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106:14670-14675.
52. + channel in a nonconducting state. Biophys J 71:3083-3090.